Related Experiment Video
Updated: Aug 28, 2025

11:49
Synthesis of Soft Polysiloxane-urea Elastomers for Intraocular Lens Application
Published on: March 8, 2019
12.7K
Premium intraocular lenses in children
Mohamed Ibrahime Asif1, Nimmy Raj1, Nidhi Kalra1
1Dr Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
European Journal of Ophthalmology
|September 20, 2022
Summary
Premium intraocular lenses (IOLs) show promise in pediatric cataract surgery, offering favorable refractive outcomes. Further research is needed on long-term effects and amblyopia management in children receiving these advanced IOLs.
Area of Science:
- Ophthalmology
- Pediatric Optometry
- Biomedical Engineering
Background:
- Premium intraocular lenses (IOLs), including multifocal and toric types, are standard for adult cataract surgery.
- Pediatric IOL implantation presents unique challenges impacting visual development, requiring careful consideration.
Purpose of the Study:
- To review factors influencing visual outcomes of premium IOLs in pediatric patients.
- To analyze the impact of age, IOL power calculation, and specific IOL types on pediatric visual results.
Main Methods:
- A comprehensive literature review was conducted up to January 31, 2022.
- Included 17 studies (10 case series/interventional, 7 case reports) on pediatric multifocal or toric IOL implantation.
- Evaluated refractive outcomes, contrast sensitivity, stereopsis, and complications.
Main Results:
- All studies reported favorable refractive outcomes, though data was limited.
- Early multifocal IOL models had higher rates of decentration and opacification; newer models show improved safety.
- Toric IOLs demonstrated promising results across evaluated studies.
Conclusions:
- Premium IOLs show potential for pediatric use, with generally positive refractive results.
- Long-term data on refractive shift, capsular contraction, and amblyopia management require further investigation.
Related Concept Videos
Glaucoma: Overview
702
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
702
Focusing of Light in the Eye
3.1K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
3.1K
Open Angle Glaucoma: Treatment
527
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
527
Angle Closure Glaucoma: Treatment
628
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
628

